Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia [2]

AIDS

Volumn 15, Issue 6, 2001, Pages 820-821

  Mastroianni, C M ^a   D'Ettorre, G ^a   Forcina, G ^a   Lichtner, M ^a   Corpolongo, A ^a   Coletta, S ^a   Vullo, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; ATORVASTATIN; BEZAFIBRATE; CERIVASTATIN; CIPROFIBRATE; DIDANOSINE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDINAVIR; MEVINOLIN; PROTEINASE INHIBITOR; SIMVASTATIN; STATIN; STEROID; ZIDOVUDINE;

ADULT; ALKALINIZATION; BODY FAT; CASE REPORT; CLINICAL FEATURE; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRATION; HYPERLIPIDEMIA; LETTER; MALE; PRIORITY JOURNAL; RHABDOMYOLYSIS; SERODIAGNOSIS; STEROID THERAPY; VIRUS LOAD;

ANTILIPEMIC AGENTS; DRUG THERAPY, COMBINATION; GEMFIBROZIL; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PYRIDINES; RHABDOMYOLYSIS;

EID: 0035853365     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200104130-00029     Document Type: Letter

References (9)

1. Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipedaemia, and diabetes mellitus: A cohort study
2. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
3. Acute rhabdomyolysis in patients infected by human immunodeficiency virus
4. Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successfully treated with ritonavir and indinavir
5. Pharmacokinetic interactions between protease inhibitors and selected HMG-CoA reductase inhibitors
6. Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection
7. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy
8. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil
9. A case with severe rhabdomyolysis and renal failure associated with cerivastatingemfibrozil combination therapy - A case report